NCT07163325 2025-09-09EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid TumorsEpics TherapeuticsPhase 1 Recruiting48 enrolled
NCT06527300 2025-01-24A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT CancerZhejiang Wenda Pharma Technology LTD.Phase 2 Recruiting48 enrolled